Category: Blood Diseases
Global Blood Diseases
-
Drugs and Diagnostics for Hematological Disorders: Global Markets
... diseases. Based on product type, the diagnostic market for hematological disorders is divided into reagents & instruments and software. By end user, the market is segmented into hospitals, diagnostic labs, and others. On the basis ... Read More
-
Global Iron-Deficiency Anemia Therapy Market
... period of 2024 to 2031. Market Segmentation: Global Iron-Deficiency Anemia Therapy Market, By Therapy (Parenteral Iron Therapy and Oral Iron Therapy), Therapy Area (Obstetrics and Gynecology, Renal Diseases, Congestive Heart Failure (CHF), Oncology, Inflammatory Bowel ... Read More
-
Anemia Drugs
... at a CAGR of 4.1% over the analysis period 2023-2030. Iron Deficiency Anemia Drugs, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$7.4 Billion by the ... Read More
-
2024 Global: Hemophilia Treatment Market - Innovative Markets Forecast (2030) report
... 2019 through 2030. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2019 to 2030 using regression ... Read More
-
Global Autoimmune Hemolytic Anemia Therapeutics Market 2024-2028
... on the autoimmune hemolytic anemia therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis ... Read More
-
Global Iron Drugs Market 2024-2028
... market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the ... Read More
-
Global Sickle Cell Anemia Therapeutics Competitive Landscape Professional Research Report 2024
... a genetic disorder characterized by abnormal hemoglobin production. Therapeutic approaches for sickle cell anemia may include disease-modifying medications such as hydroxyurea, which increases fetal hemoglobin production and reduces the frequency of painful vaso-occlusive crises. Other ... Read More
-
Global Hemophilia Gene Therapy Competitive Landscape Professional Research Report 2024
... Typically, hemophilia gene therapy involves introducing a functional copy of the clotting factor gene into the patient＇s cells, often using viral vectors as delivery vehicles. The goal is to enable the patient＇s cells to produce ... Read More
-
Specialty Drug Distribution Market by Disease Indication (AIDS, Hemophilia, Multiple Sclerosis), Distributor Type (Full line Wholesalers, Specialty Distributors), Distribution Type, End-User - Global Forecast 2024-2030
... 4.76 billion in 2023 and expected to reach USD 5.47 billion in 2024, at a CAGR 14.44% to reach USD 12.25 billion by 2030. Specialty drugs are normally complex to manufacture, high-cost medications requiring specialized ... Read More
-
Hemoglobin Testing Market by Type (Blood Glucose Testing, Cyanmethemoglobin Method, Hemoglobin Electrophoresis), Technology (Laboratory Testing, Point-of-Care Testing), Operation, Application, End-User - Global Forecast 2024-2030
... in 2023 and expected to reach USD 6.04 billion in 2024, at a CAGR 6.10% to reach USD 8.63 billion by 2030. The hemoglobin testing market comprises various diagnostic products, services, and technologies that healthcare ... Read More
-
Sickle Cell Anemia Testing & Screening Market by Technology (Hemoglobin Electrophoresis, High-performance Liquid Chromatography (HPLC), Point-of-Care Tests), Age Group (Adult Screening, Newborn Screening, Years 1 to 25), Sector - Global Forecast 2024-2030
... Anemia Testing & Screening Market size was estimated at USD 943.95 million in 2023 and expected to reach USD 1,070.69 million in 2024, at a CAGR 13.51% to reach USD 2,293.22 million by 2030. Sickle ... Read More
-
Sickle Cell Disease Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
... Africa) The global sickle cell disease treatment market encounters numerous challenges that impede its revenue growth. These challenges stem from inadequate healthcare infrastructure, unavailability of drugs in rural regions, lack of reimbursement, high treatment costs, ... Read More
-
2024 Global Forecast for Plasma Fractionation Market (2025-2030 Outlook)-High Tech & Emerging Markets Report
... product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx billion in ... Read More
-
Global Rare Hemophilia Factors Databank Market Report
... 2021 to 2029. Factor II segment is expected to be the highest contributor to this market, with $1,123.8 Million in 2020, and is anticipated to reach $1,801.8 Million by 2029, registering a CAGR of 5.44%. ... Read More
-
Global Hematologic Malignancies Databank Market Report
... 2029. Leukemia segment is expected to be the highest contributor to this market, with $13,172.5 Million in 2020, and is anticipated to reach $25,934.9 Million by 2029, registering a CAGR of 7.87%. Lymphoma segment is ... Read More
-
Global Hemophilia Gene Therapy Market Analysis and Forecast 2024-2030
... genetic defect in a single gene). There are two types of hemophilia caused by mutations in genes that encode protein factors which help the blood clot and stop bleeding when blood vessels are injured. Individuals ... Read More
-
Global Hemophilia Gene Therapy Market Size, Manufacturers, Growth Analysis Industry Forecast to 2030
... is caused by a genetic defect in a single gene). There are two types of hemophilia caused by mutations in genes that encode protein factors which help the blood clot and stop bleeding when blood ... Read More
-
Global Hemophilia Gene Therapy Market Size, Manufacturers, Opportunities and Forecast to 2030
... caused by a genetic defect in a single gene). There are two types of hemophilia caused by mutations in genes that encode protein factors which help the blood clot and stop bleeding when blood vessels ... Read More
-
Global Hemophilia Gene Therapy Market by Size, by Type, by Application, by Region, History and Forecast 2019-2030
... disease (a disease that is caused by a genetic defect in a single gene). There are two types of hemophilia caused by mutations in genes that encode protein factors which help the blood clot and ... Read More
-
Global Thalassemia Market - 2024-2031
... 2024-2031. Thalassemia represents a substantial health burden, particularly in regions where the prevalence is high. Individuals with severe forms of thalassemia require lifelong medical care, including blood transfusions, iron chelation therapy, and management of complications ... Read More
-
Global chemotherapy-induced thrombocytopenia Market - 2023-2030
... forecast period 2023-2030. Chemotherapy-induced thrombocytopenia (CIT) is characterized by a decreased platelet count in the blood as a result of chemotherapy treatment. Because platelets are necessary for blood clotting, a drop in their number can ... Read More
-
Global Anemia Treatment Drugs Market Growth (Status and Outlook) 2024-2030
... in downstream market, the Anemia Treatment Drugs is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the ... Read More
-
Global Alpha Thalassemia Treatment Market Growth (Status and Outlook) 2024-2030
... in downstream market, the Alpha Thalassemia Treatment is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the ... Read More
-
Acquired Hemophilia Treatment Global Market Report 2024
... Bristol-Myers Squibb Company Acquired Hemophilia Treatment Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market. This report focuses on ... Read More
-
Global Iron Deficiency Anemia Drug Market Growth (Status and Outlook) 2024-2030
... With growing demand in downstream market, the Iron Deficiency Anemia Drug is forecast to a readjusted size of US$ 2372.1 million by 2030 with a CAGR of 5.2% during review period. The research report highlights ... Read More
Research Assistance
